Home › A New Understanding

A New Understanding

SIBO (Small Intestinal Bacterial Overgrowth) Irritable bowel syndrome (IBS) is the most common chronic medical condition and is characterized by abdominal pain, bloating, and altered bowel habits. Up to 20% of people are affected by IBS, regardless of age. Unlike heart disease, IBS impacts daily life with symptoms like

Published on August 10, 2016 by Bobbi Walton

SIBO (Small Intestinal Bacterial Overgrowth)


Irritable bowel syndrome (IBS) is the most common chronic medical condition and is characterized by abdominal pain, bloating, and altered bowel habits. Up to 20% of people are affected by IBS, regardless of age. Unlike heart disease, IBS impacts daily life with symptoms like gas and bloating, which often carry social stigma. However, it is now widely recognized as a legitimate medical condition with new treatments emerging.


Scientists from around the world have shown the benefits of allicin (not garlic) in balancing gut bacteria. Our patented process produces a stable, bioactive form of allicin with published research demonstrating broad-spectrum action against bacteria, fungus, parasites, and viruses. Clinicians report positive outcomes with AlliUltra® and Allimed®, especially where pharmaceuticals are not preferred.


Benefits:

 

  • Microbial balancing

  • Clinically proven

  • Recommended by experts

  • Backed by university research

  • Patented manufacturing

  • Bioactive stabilized allicin

 

 


 

 

🛍️

Special Offer

 


SAVE 15% NOW on AlliUltra / Allimed

CODE: AM4IBS – valid through August 31

Not valid with any other promotion

Related Articles

Sign up for our newsletter

Be the first to know about releases and industry news and insights.